Nicoya®, a pioneering life science instrument company specializing in innovative biosensor technologies, announces the launch of the Alto Automation Suite™ for its flagship Alto Digital SPR™ system. This makes Alto the world’s first SPR platform that is fully compatible with standard lab automation, enabling thousands of samples per week...
Custom robotic workstation automates company’s broad portfolio of biology assays for academia, biotech, and pharma
MilliporeSigma, the U.S. and Canada c business of Merck KGaA, Darmstadt, Germany, and Opentrons Labworks, Inc., a leader in lab automation and accessible robotics, announced a multi-year agreement to automate assay kits on a custom...
This strategic acquisition combines healthcare intelligence with advanced actuarial expertise to improve healthcare outcomes and lay a foundation for Actuarial Copilots
Innovaccer, a leading healthcare AI company, announced its acquisition of Humbi AI (Actuarial Intelligence), a specialized healthcare actuarial software, services and analytics company. This marks Innovaccer’s third acquisition, following Cured and Pharmacy Quality Solutions...
Mayo Clinic unveiled separate groundbreaking collaborations with Microsoft Research and with Cerebras Systems in the field of generative artificial intelligence (AI), designed to personalize patient care, significantly accelerate diagnostic time and improve accuracy.
Announced during the 43rd Annual J.P. Morgan Healthcare Conference, the projects focus on developing and testing foundation...
Diaceutics, a leading technology and solutions provider to the life science industry, and Cornerstone AI, a leading AI-based data quality and data enhancement platform, announced a strategic partnership to enhance the accuracy, completeness and usability of data from the DXRX laboratory network.
The collaboration integrates Cornerstone AI's proprietary lab data algorithms...
The collaboration brings together Caris' extensive genomic data and molecular expertise with Ontada's robust clinical data and research capabilities to drive next-gen therapeutic development and advance cancer care
Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, announced a strategic and multi-faceted collaboration with Ontada®, a...
Proposed collaboration aims to integrate cutting-edge AI and genomic insights to advance guideline-directed medical therapy
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, announced a proposed collaboration with Guardant Health, Inc., a leading precision oncology company, to address challenges in lung cancer care. The collaboration aims to...
Atropos Health’s platform, including GENEVA OS™ and the Atropos Evidence™ Network Launches AI Model for Precision Medicine at Scale
Atropos Health, the pioneer in translating real-world clinical data into personalized real-world evidence, announced the deployment of AI models for patient identification of patients living with undiagnosed conditions. The AI models...
IQVIA, a leading global provider of clinical research services, commercial insights, and healthcare intelligence, announced a strategic collaboration with NVIDIA to help realize the potential of AI in healthcare and life sciences.
The healthcare and life sciences industries generate vast amounts of data, representing significant potential for AI-powered solutions. This...
Totus Medicines, a company revolutionizing small molecule drug discovery and development using covalent DNA-encoded libraries and AI tools, announced the initiation of an indication expansion study of TOS-358, the first covalent PI3Kα inhibitor in clinical development and the appointment of Zelanna Goldberg, M.D., M.A.S., as Chief Medical Officer.
“Following the...
